Literature DB >> 17277146

Rapid clonal expansion and prolonged maintenance of memory CD8+ T cells of the effector (CD44highCD62Llow) and central (CD44highCD62Lhigh) phenotype by an archaeosome adjuvant independent of TLR2.

Lakshmi Krishnan1, Komal Gurnani, Chantal J Dicaire, Henk van Faassen, Ahmed Zafer, Carsten J Kirschning, Subash Sad, G Dennis Sprott.   

Abstract

Vaccines capable of eliciting long-term T cell immunity are required for combating many diseases. Live vectors can be unsafe whereas subunit vaccines often lack potency. We previously reported induction of CD8(+) T cells to Ag entrapped in archaeal glycerolipid vesicles (archaeosomes). In this study, we evaluated the priming, phenotype, and functionality of the CD8(+) T cells induced after immunization of mice with OVA-Methanobrevibacter smithii archaeosomes (MS-OVA). A single injection of MS-OVA evoked a profound primary response but the numbers of H-2K(b)OVA(257-264)-specific CD8(+) T cells declined by 14-21 days, and <1% of primarily central phenotype (CD44(high)CD62L(high)) cells persisted. A booster injection of MS-OVA at 3-11 wk promoted massive clonal expansion and a peak effector response of approximately 20% splenic/blood OVA(257-264)-specific CD8(+) T cells. Furthermore, contraction was protracted and the memory pool (IL-7Ralpha(high)) of approximately 5% included effector (CD44(high)CD62L(low)) and central (CD44(high)CD62L(high)) phenotype cells. Recall response was observed even at >300 days. CFSE-labeled naive OT-1 (OVA(257-264) TCR transgenic) cells transferred into MS-OVA-immunized recipients cycled profoundly (>90%) within the first week of immunization indicating potent Ag presentation. Moreover, approximately 25% cycling of Ag-specific cells was seen for >50 days, suggesting an Ag depot. In vivo, CD8(+) T cells evoked by MS-OVA killed >80% of specific targets, even at day 180. MS-OVA induced responses similar in magnitude to Listeria monocytogenes-OVA, a potent live vector. Furthermore, protective CD8(+) T cells were induced in TLR2-deficient mice, suggesting nonengagement of TLR2 by archaeal lipids. Thus, an archaeosome adjuvant vaccine represents an alternative to live vectors for inducing CD8(+) T cell memory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277146     DOI: 10.4049/jimmunol.178.4.2396

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical.

Authors:  Yi He; Marc S Weinberg; Matt Hirsch; Mark C Johnson; Roland Tisch; R Jude Samulski; Chengwen Li
Journal:  Hum Gene Ther       Date:  2013-05-02       Impact factor: 5.695

2.  Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease.

Authors:  Leticia H Higa; Ricardo S Corral; María José Morilla; Eder L Romero; Patricia B Petray
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

3.  Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

Authors:  Susan M Twine; Kelly M Fulton; John Spika; Marc Ouellette; Jennifer F Raven; J Wayne Conlan; Lakshmi Krishnan; Luis Barreto; James C Richards
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.

Authors:  Julia Kim; Vandana Gambhir; Attiya Alatery; Sameh Basta
Journal:  J Biomed Biotechnol       Date:  2010-05-23

5.  A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.

Authors:  Yuhua Li; Shifeng Wang; Wei Xin; Giorgio Scarpellini; Zhaoxing Shi; Bronwyn Gunn; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

6.  Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.

Authors:  Bassel Akache; Felicity C Stark; Umar Iqbal; Wangxue Chen; Yimei Jia; Lakshmi Krishnan; Michael J McCluskie
Journal:  Hum Vaccin Immunother       Date:  2018-01-30       Impact factor: 3.452

7.  Lymphotoxin-alpha and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy.

Authors:  Deanna A Hagge; Bernadette M Saunders; Gigi J Ebenezer; Nashone A Ray; Vilma T Marks; Warwick J Britton; James L Krahenbuhl; Linda B Adams
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

8.  Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses.

Authors:  Lakshmi Krishnan; Lise Deschatelets; Felicity C Stark; Komal Gurnani; G Dennis Sprott
Journal:  Clin Dev Immunol       Date:  2011-01-18

9.  Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity.

Authors:  Karen A O Martins; Christopher L Cooper; Sabrina M Stronsky; Sarah L W Norris; Steven A Kwilas; Jesse T Steffens; Jacqueline G Benko; Sean A van Tongeren; Sina Bavari
Journal:  EBioMedicine       Date:  2015-11-27       Impact factor: 8.143

10.  Ether lipid vesicle-based antigens impart protection against experimental listeriosis.

Authors:  Mairaj Ahmed Ansari; Swaleha Zubair; Saba Tufail; Ejaj Ahmad; Mohsin Raza Khan; Zainuddin Quadri; Mohammad Owais
Journal:  Int J Nanomedicine       Date:  2012-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.